Cargando…
Novel Diagnostic Tool for p47(phox)-Deficient Chronic Granulomatous Disease Patient and Carrier Detection
Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by mutations of the phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Autosomal recessive p47(phox)-deficient CGD (p47(phox) CGD) is the second most frequent form of the disease in western countries, and m...
Autores principales: | Wrona, Dominik, Siler, Ulrich, Reichenbach, Janine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395829/ https://www.ncbi.nlm.nih.gov/pubmed/30859112 http://dx.doi.org/10.1016/j.omtm.2019.02.001 |
Ejemplares similares
-
CRISPR/Cas9-generated p47(phox)-deficient cell line for Chronic Granulomatous Disease gene therapy vector development
por: Wrona, Dominik, et al.
Publicado: (2017) -
The p47phox mouse knock-out model of chronic granulomatous disease
Publicado: (1995) -
Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47(phox)-Deficient Chronic Granulomatous Disease
por: Schejtman, Andrea, et al.
Publicado: (2021) -
Lentiviral gene therapy rescues p47(phox) chronic granulomatous disease and the ability to fight Salmonella infection in mice
por: Schejtman, Andrea, et al.
Publicado: (2020) -
Long-term outcome of patients with p22(phox)-deficient chronic granulomatous disease on Jeju Island, Korea
por: Kang, Hyun Sik, et al.
Publicado: (2015)